Optimer Pharmaceuticals Inc ( OPTR) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 2.5%. By the end of trading, Optimer Pharmaceuticals Inc rose 39 cents (3.8%) to $10.60 on light volume. Throughout the day, 817,168 shares of Optimer Pharmaceuticals Inc exchanged hands as compared to its average daily volume of 1.4 million shares. The stock ranged in a price between $10.07-$10.90 after having opened the day at $10.17 as compared to the previous trading day's close of $10.21. Other companies within the Health Care sector that increased today were: Transcept Pharmaceuticals Inc ( TSPT), up 11%, Cormedix Inc ( CRMD), up 9.6%, China Cord Blood Corporation ( CO), up 9.4%, and Inhibitex Inc ( INHX), up 9.2%.

Optimer Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing hospital specialty products worldwide. It develops products that treat gastrointestinal infections and related diseases. Optimer Pharmaceuticals Inc has a market cap of $485.6 million and is part of the drugs industry. Shares are down 9.7% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Optimer as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and weak operating cash flow.

On the negative front, Rosetta Genomics ( ROSG), down 43.3%, Rosetta Genomics ( ROSGD), down 43.3%, Accelr8 Technology Corporation ( AXK), down 16.4%, and Bacterin International Holdings Inc ( BONE), down 14.7%, were all losers within the health care sector with WellPoint Inc ( WLP) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).
null